Novelmed Therapeutics Inc SBIR Phase I Award, July 2021
A SBIR Phase I contract was awarded to Novelmed Therapeutics Inc in July, 2021 for $533,165.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Novelmed Therapeutics Inc SBIR Phase I Award, July 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
